RxDoctor Payments Data

Kishore Sriram, MD

Child & Adolescent Psychiatry · Warsaw, INNPI 1710179908

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,479 of the $1,651 with a category attached, or 89.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $632 and has fallen 74.5% since, to $161 in 2025.

$1,651in general payments, 2019–2025

Across 96 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$383
  • Jazz Pharmaceuticals Inc.$194
  • Otsuka America Pharmaceutical, Inc.$176
  • Alkermes, Inc.$158
  • Johnson & Johnson$98
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$70
  • plus $573 from 17 others

What the payments were for

  • Food & beverage$1,47990%
  • Education$17210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,651 in reported general payments places this provider in the 75th percentile of 56 child & adolescent psychiatry providers in Indiana.

See all child & adolescent psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$4,291
Medicare patients
16
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate41$133,223
AustedoDeutetrabenazine19$114,995
TrintellixVortioxetine Hydrobromide124$65,180
Abilify MaintenaAripiprazole23$63,215
Aripiprazole280$36,610
FanaptIloperidone32$31,836
VraylarCariprazine Hcl19$31,125
RexultiBrexpiprazole12$19,351
Lurasidone Hcl183$17,970
Paliperidone ErPaliperidone68$17,558
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl136$15,190
Clozapine78$9,105
NamzaricMemantine Hcl/Donepezil Hcl13$8,058
ZubsolvBuprenorphine Hcl/Naloxone Hcl28$7,258
Buspirone Hcl629$6,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$98$133,22341 claims
Teva Pharmaceuticals USA, Inc.Austedo$37$114,99519 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$176$82,56635 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$45$65,180124 claims
Vanda Pharmaceuticals Inc.Fanapt$55$31,83632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 56 child & adolescent psychiatry providers in Indiana.

Other child & adolescent psychiatry in Warsaw

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →